Home Featured Page 239

Featured

Latest

Colorado’s Psilocybin Supply Chain Complete: First Testing Lab Licensed, Sessions Could Begin This Month

Pα+ Psychedelic Bulletin #196: Otsuka Eyes Psychedelic Future in Japan; First Look at Gilgamesh’s Phase 2a Data; ASCP 2025 Preview; VA Sec. Pressed on...

EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic Access for Veterans

Ibogaine – The Promise, the Protocol, and Protecting the Sacred

Pα+ Psychedelic Bulletin #195: Psychedelics Namechecked in Trump Cabinet Meeting; Noma Therapy Aims to Disrupt At-Home Ketamine; Christian Angermayer on the Politics and Business...

COMPASS Pathways plc announces financial results and business highlights for the...

PharmaDrug Enters into Employment Agreement with Dr. Paul Van Slyke and...

The World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts...

Silo Pharma announces important milestone. Investigator led study using Psilocybin to...

Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and...

MindMed Bolsters Management Team, Appoints Peter Mack PhD as Vice President...

Silo Wellness Partners with Kaivalya Kollectiv to Include 5-MeO-DMT In Psychedelic...

IntelGenx Announces Shareholder Approval of atai Investment

Exploring Oregon’s Measure 110 and The Future of Drug Policy Reform

IntelGenx Expands Psychedelics Collaboration with atai Life Sciences with Signing of...

1...238239240...286 Page 239 of 286

Colorado’s Psilocybin Supply Chain Complete: First Testing Lab Licensed, Sessions Could...

Pα+ Psychedelic Bulletin #196: Otsuka Eyes Psychedelic Future in Japan; First...

EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.